ARCHIVES

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Accidents Claim Wisconsin’s William Caldwell, John Wear; Murchison, Nance To Head Nalsi

June 15, 1979

NCI relaxes Core Grants Support For Clinical Trials Research

December 11, 1992

Omnibus bill recissions would cut $28 million from NCI FY04 budget.

January 9, 2004

In Brief: Contract Vs. Grants A Non-Issue, Upton Says In Farewell Appearance; Conte Eyes Chairmanship

January 18, 1980

Minority Professional Training Concept Gets Approval Of NCAB

March 1, 1991

HEW To Pay All Care Cost At 26 Hospices

January 11, 1980